Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 272-281

  Chuma, Makoto ^a   Sakamoto, Naoya ^a   Nakai, Akira ^b   Hige, Shuhei ^a   Nakanishi, Mitsuru ^a   Natsuizaka, Mitsuteru ^a   Suda, Goki ^a   Sho, Takuya ^a   Hatanaka, Kanako ^a   Matsuno, Yoshihiro ^a   Yokoo, Hideki ^a   Kamiyama, Toshiya ^a   Taketomi, Akinobu ^a   Fujii, Gen ^c   Tashiro, Kosuke ^d   Hikiba, Yoko ^e   Fujimoto, Mitsuaki ^b   Asaka, Masahiro ^a   Maeda, Shin ^f  

^a HOKKAIDO UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e INSTITUTE FOR ADULT DISEASES   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BAG 3 PROTEIN; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA-BINDING PROTEINS; HEPATOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84893349967     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt343     Document Type: Article

References (43)

1. El-Serag,H.B. (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-1273.e1.
2. Cheng,A.L. et al. (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol., 10, 25-34.
3. Breuhahn,K. et al. (2011) Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. Hepatology, 53, 2112-2121.
4. Pirkkala,L. et al. (2001) Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J., 15, 1118-1131.
5. Sorger,P.K. (1991) Heat shock factor and the heat shock response. Cell, 65, 363-366.
6. Guertin,M.J. et al. (2010) Chromatin landscape dictates HSF binding to target DNA elements. PLoS Genet., 6, e1001114.
7. Mendillo,M.L. et al. (2012) HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell, 150, 549-562.
8. Page,T.J. et al. (2006) Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. Mol. Biosyst., 2, 627-639.
9. Dai,C. et al. (2007) Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell, 130, 1005-1018.
10. Hayashida,N. et al. (2006) A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. EMBO J., 25, 4773-4783.
11. Jacobs,A.T. et al. (2007) Heat shock factor 1 attenuates 4-hydroxynonenalmediated apoptosis: critical role for heat shock protein 70 induction and stabilization of Bcl-XL. J. Biol. Chem., 282, 33412-33420.
12. Vydra,N. et al. (2006) Spermatocyte-specific expression of constitutively active heat shock factor 1 induces HSP70i-resistant apoptosis in male germ cells. Cell Death Differ., 13, 212-222.
13. Neckers,L. et al. (2012) Hsp90 molecular chaperone inhibitors: are we there yet? Clin. Cancer Res., 18, 64-76.
14. Khalil,A.A. et al. (2011) Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim. Biophys. Acta, 1816, 89-104.
15. Chuma,M. et al. (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology, 37, 198-207.
16. Cai,L. et al. (2003) The tumor-selective over-expression of the human Hsp70 gene is attributed to the aberrant controls at both initiation and elongation levels of transcription. Cell Res., 13, 93-109.
17. Min,J.N. et al. (2007) Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene, 26, 5086-5097.
18. Santagata,S. et al. (2011) High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc. Natl Acad. Sci. USA, 108, 18378-18383.
19. Dudeja,V. et al. (2011) Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors. Am. J. Physiol. Gastrointest. Liver Physiol., 300, G948-G955.
20. Hoang,A.T. et al. (2000) A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am. J. Pathol., 156, 857-864.
21. Ishiwata,J. et al. (2012) State of heat shock factor 1 expression as a putative diagnostic marker for oral squamous cell carcinoma. Int. J. Oncol., 40, 47-52.
22. Kojiro,M. et al. (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology, 49, 658-664.
23. Fabregat,I. et al. (2007) Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int., 27, 155-162.
24. Nakagawa,H. et al. (2011) Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase. Hepatology, 54, 185-195.
25. Sun,B. et al. (2008) NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene, 27, 6228-6244.
26. Maeda,S. et al. (2005) IKKbeta couples hepatocyte death to cytokinedriven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell, 121, 977-990.
27. Beeram,M. et al. (2005) Raf: a strategic target for therapeutic development against cancer. J. Clin. Oncol., 23, 6771-6790.
28. Whittaker,S. et al. (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene, 29, 4989-5005.
29. Inouye,S. et al. (2003) Activation of heat shock genes is not necessary for protection by heat shock transcription factor 1 against cell death due to a single exposure to high temperatures. Mol. Cell. Biol., 23, 5882-5895.
30. Chuma,M. et al. (2004) Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol., 41, 629-636.
31. O'Callaghan-Sunol,C. et al. (2006) Heat shock transcription factor (HSF1) plays a critical role in cell migration via maintaining MAP kinase signaling. Cell Cycle, 5, 1431-1437.
32. Nowak,M. et al. (2000) LPS-induced liver injury in D-galactosaminesensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol., 278, R1202-R1209.
33. Ammirante,M. et al. (2010) IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc. Natl Acad. Sci. USA, 107, 7497-7502.
34. Meng,L. et al. (2010) Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene, 29, 5204-5213.
35. Solimini,N.L. et al. (2007) Non-oncogene addiction and the stress phenotype of cancer cells. Cell, 130, 986-988.
36. Malhotra,V. et al. (2002) Heat shock inhibits activation of NF-kappaB in the absence of heat shock factor-1. Biochem. Biophys. Res. Commun., 291, 453-457.
37. Janus,P. et al. (2011) NF-κB signaling pathway is inhibited by heat shock independently of active transcription factor HSF1 and increased levels of inducible heat shock proteins. Genes Cells, 16, 1168-1175.
38. Rosati,A. et al. (2011) BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis., 2, e141.
39. Homma,S. et al. (2006) BAG3 deficiency results in fulminant myopathy and early lethality. Am. J. Pathol., 169, 761-773.
40. Franceschelli,S. et al. (2008) Bag3 gene expression is regulated by heat shock factor 1. J. Cell. Physiol., 215, 575-577.
41. Luo,J.L. et al. (2005) IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Invest., 115, 2625-2632.
42. Jin,X. et al. (2011) Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab., 14, 91-103.
43. Luedde,T. et al. (2007) Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell, 11, 119-132.